Add to ORKGBACKGROUND: There is growing interest in using C-reactive protein (CRP) levels to help select patients for lipid lowering therapy—although this practice is not yet supported by evidence of benefit in a randomized trial. OBJECTIVE: To estimate the number of Americans potentially affected if a CRP criteria were adopted as an additional indication for lipid lowering therapy. To provide context, we also determined how well current lipid lowering guidelines are being implemented. METHODS: We analyzed nationally representative data to determine how many Americans age 35 and olde
OBJECTIVE: To estimate numbers affected by a recent change in UK guidelines for statin use in primar...
CONTEXT: Human adipose tissue expresses and releases the proinflammatory cytokine interleukin 6, pot...
centration and insulin resistance (IR) are associated with increased rates of adverse cardiovascular...
C-reactive protein (CRP) is a well-known biomarker of systemic inflammation and cardiovascular disea...
ObjectivesWe assessed the prevalence of low-density lipoprotein-cholesterol (LDL-C) <130 mg/dl with ...
BACKGROUND: There is debate about the value of assessing levels of C-reactive protein (CRP) and othe...
The purpose of the present substudy of the Lipid Treatment Assessment Project 2 was to assess dual C...
BACKGROUND: There is debate about the value of assessing levels of C-reactive protein (CRP) and othe...
Background: There is debate about the value of assessing levels of C-reactive protein (CRP) and othe...
Background: C-Reactive protein (CRP) has been shown to be a strong predictor of coronary heart disea...
Background: Given the results of the Justification for the Use of Statins in Primary Prevention: An ...
Background There is debate about the value of assessing levels of C-reactive protein (CRP) and other...
Item does not contain fulltextBACKGROUND: Epidemiologic studies have shown that C-reactive protein (...
Abstract. C-reactive protein (CRP), a nonspecific inflammatory marker, is widely used to monitor tre...
The American Heart Association estimates that by 2035 over 130 million or 45.1 percent of the Americ...
OBJECTIVE: To estimate numbers affected by a recent change in UK guidelines for statin use in primar...
CONTEXT: Human adipose tissue expresses and releases the proinflammatory cytokine interleukin 6, pot...
centration and insulin resistance (IR) are associated with increased rates of adverse cardiovascular...
C-reactive protein (CRP) is a well-known biomarker of systemic inflammation and cardiovascular disea...
ObjectivesWe assessed the prevalence of low-density lipoprotein-cholesterol (LDL-C) <130 mg/dl with ...
BACKGROUND: There is debate about the value of assessing levels of C-reactive protein (CRP) and othe...
The purpose of the present substudy of the Lipid Treatment Assessment Project 2 was to assess dual C...
BACKGROUND: There is debate about the value of assessing levels of C-reactive protein (CRP) and othe...
Background: There is debate about the value of assessing levels of C-reactive protein (CRP) and othe...
Background: C-Reactive protein (CRP) has been shown to be a strong predictor of coronary heart disea...
Background: Given the results of the Justification for the Use of Statins in Primary Prevention: An ...
Background There is debate about the value of assessing levels of C-reactive protein (CRP) and other...
Item does not contain fulltextBACKGROUND: Epidemiologic studies have shown that C-reactive protein (...
Abstract. C-reactive protein (CRP), a nonspecific inflammatory marker, is widely used to monitor tre...
The American Heart Association estimates that by 2035 over 130 million or 45.1 percent of the Americ...
OBJECTIVE: To estimate numbers affected by a recent change in UK guidelines for statin use in primar...
CONTEXT: Human adipose tissue expresses and releases the proinflammatory cytokine interleukin 6, pot...
centration and insulin resistance (IR) are associated with increased rates of adverse cardiovascular...